Determining Clinical Follow-Up in the Context of Widening LAI Intervals: How Long Is Too Long?
J Clin Psychiatry
.
2023 May 31;84(4):23com14680.
doi: 10.4088/JCP.23com14680.
Authors
Samuel J Dotson
1
2
,
Robert O Cotes
3
,
Oliver Freudenreich
4
Affiliations
1
Department of Psychiatry, Atrium Health and Wake Forest University School of Medicine, Charlotte, North Carolina.
2
Corresponding author: Samuel J. Dotson, MD, Charlotte Behavioral Health AIC Clinic, 501 Billingsley Rd, Charlotte NC, 28211 (
[email protected]
).
3
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia.
4
Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts.
PMID:
37256637
DOI:
10.4088/JCP.23com14680
No abstract available
MeSH terms
Antipsychotic Agents* / therapeutic use
Delayed-Action Preparations
Follow-Up Studies
Humans
Risperidone
Substances
Antipsychotic Agents
Risperidone
Delayed-Action Preparations